8% Off
Saglit15 mg
Synovia Pharma PLC
৳7.39
Add to cart
Generic medicine
Pioglitazone: Brands, Price & Uses in Bangladesh
Pioglitazone is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
About Pioglitazone
Indications of Pioglitazone
Pioglitazone is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
- Established/approved use: Monotherapy for type 2 diabetes mellitus when diet and exercise alone are inadequate.
- Combination therapy (requires an additional agent): Pioglitazone is also approved for use in combination with metformin, a sulfonylurea, or insulin when the current regimen does not provide adequate glycemic control.
- Guideline-supported adjunct role: Sometimes used as part of multi-drug regimens in insulin-resistant type 2 diabetes, particularly when weight-neutral or insulin-sparing options are limited.
- Off-label (not FDA-approved, used selectively based on clinical judgment): Non-alcoholic steatohepatitis (NASH) in patients with type 2 diabetes or prediabetes, based on evidence from clinical trials; this use should only be undertaken under specialist supervision.
Pioglitazone is not indicated for type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
Dosage & Administration of Pioglitazone
General principles
Pioglitazone is taken orally once daily, with or without food. Therapy is individualized based on glycemic response and tolerability, and dose changes should be made gradually with monitoring.
| Indication / Setting | Typical adult dosing |
|---|---|
| Monotherapy | Initiate at 15 mg or 30 mg once daily; may be titrated in increments up to a maximum of 45 mg once daily based on response. |
| Combination with metformin or a sulfonylurea | Initiate Pioglitazone at 15 mg or 30 mg once daily added to the existing regimen; titrate as needed up to 45 mg once daily. The dose of the sulfonylurea may need to be reduced if hypoglycemia occurs. |
| Combination with insulin | Initiate Pioglitazone at 15 mg or 30 mg once daily while continuing insulin; monitor closely for fluid retention and signs of heart failure. The insulin dose may need to be reduced if hypoglycemia occurs. |
| Hepatic impairment | Pioglitazone should not be initiated in patients with active liver disease or baseline ALT greater than 2.5 times the upper limit of normal; use with caution and monitor liver enzymes in other hepatic impairment. |
| Renal impairment | No dose adjustment of Pioglitazone itself is required based on renal function, but caution is advised when used with insulin or sulfonylureas due to hypoglycemia risk. |
| Pediatric use | Safety and efficacy have not been established in patients under 18 years of age; not recommended. |
Maximum recommended dose: 45 mg once daily (30 mg once daily when used in combination with insulin, unless otherwise advised by the treating physician).
Side Effects of Pioglitazone
Common side effects
- Upper respiratory tract infection, headache, sinusitis
- Weight gain
- Mild to moderate peripheral edema (fluid retention)
- Myalgia (muscle pain)
- Mild anemia (dilutional, from fluid retention)
Serious side effects (seek prompt medical attention)
- Signs of new or worsening heart failure — rapid weight gain, swelling, shortness of breath (see Precautions and Warnings)
- Bone fractures, more frequently reported in women, typically involving the hand, foot, or distal limbs
- Signs of liver injury — unusual fatigue, loss of appetite, dark urine, yellowing of the skin or eyes
- Vision changes suggestive of macular edema
- Blood in urine or new urinary symptoms (see Precautions and Warnings regarding bladder cancer risk)
Contraindications of Pioglitazone
- Known hypersensitivity to Pioglitazone or any component of the formulation.
- New York Heart Association (NYHA) Class III or IV heart failure (established or history of), because of the risk of causing or worsening heart failure.
Pioglitazone is not appropriate for type 1 diabetes mellitus or diabetic ketoacidosis, as it is not effective for these conditions (this is a labeled non-indication rather than a pharmacologic contraindication).
Frequently Asked Questions about Pioglitazone
What is Pioglitazone used for?
Pioglitazone is used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It may be used alone or together with metformin, a sulfonylurea, or insulin.
How should I take Pioglitazone?
Pioglitazone is usually taken by mouth once daily, with or without food, at about the same time each day. Do not change your dose or stop taking it without talking to your physician first.
Can Pioglitazone cause heart problems?
Yes. Pioglitazone carries a boxed warning because it can cause or worsen congestive heart failure in some patients. Contact your physician promptly if you notice rapid weight gain, swelling in your legs or ankles, or shortness of breath. Pioglitazone should not be used by people with severe (NYHA Class III or IV) heart failure.
Is Pioglitazone linked to bladder cancer?
Some studies have suggested a possible association between long-term, higher-dose use of Pioglitazone and bladder cancer, although the evidence is not fully consistent. As a precaution, Pioglitazone is avoided in people with active bladder cancer and used cautiously in those with a past history of it. Tell your physician right away if you notice blood in your urine or new urinary symptoms.
Is Pioglitazone safe during pregnancy or breastfeeding?
Pioglitazone should be used in pregnancy only if clearly needed and if the benefit outweighs the potential risk to the baby; insulin is generally preferred for diabetes control in pregnancy. It is not known whether Pioglitazone passes into breast milk, so breastfeeding mothers should consult their physician before use. Pioglitazone can also cause ovulation to resume in some women who were not previously ovulating, so contraception should be discussed.
What are the common side effects of Pioglitazone?
Common side effects include weight gain, mild swelling (fluid retention), upper respiratory infections, headache, and muscle pain. Serious but less common effects include heart failure symptoms, bone fractures (especially in women), liver problems, and vision changes; report these to your physician promptly.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.